214 related articles for article (PubMed ID: 27356578)
1. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
2. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
3. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
Mapara MY; Bommert K; Bargou RC; Leng C; Beck C; Ludwig WD; Gierschik P; Dörken B
Blood; 1995 Apr; 85(7):1836-42. PubMed ID: 7703490
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.
Romanets-Korbut O; Najakshin AM; Yurchenko M; Malysheva TA; Kovalevska L; Shlapatska LM; Zozulya YA; Taranin AV; Horvat B; Sidorenko SP
PLoS One; 2015; 10(2):e0118302. PubMed ID: 25710480
[TBL] [Abstract][Full Text] [Related]
5. CD150-mediated Akt signalling pathway in normal and malignant B cells.
Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
[TBL] [Abstract][Full Text] [Related]
6. SLAMF1/CD150 expression and topology in prostate and breast cancer cell lines.
Gordiienko IM; Lykhova OO; Shcherbina VM; Shlapatska LM
Exp Oncol; 2021 Dec; 43(4):312-316. PubMed ID: 34967540
[TBL] [Abstract][Full Text] [Related]
7. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
[TBL] [Abstract][Full Text] [Related]
8. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
9. SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?
Gordiienko I; Shlapatska L; Kovalevska L; Sidorenko SP
Clin Immunol; 2019 Jul; 204():14-22. PubMed ID: 30616923
[TBL] [Abstract][Full Text] [Related]
10. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
11. SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.
Gordiienko I; Shcherbina V; Shlapatska L
Exp Oncol; 2024 Feb; 45(4):457-462. PubMed ID: 38328844
[TBL] [Abstract][Full Text] [Related]
12. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
[TBL] [Abstract][Full Text] [Related]
13. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
14. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
15. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
16. C-kit receptors in childhood malignant lymphoblastic cells.
Sykora KW; Tomeczkowski J; Reiter A
Leuk Lymphoma; 1997 Apr; 25(3-4):201-16. PubMed ID: 9168431
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
18. Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
Kobayashi M; Nakamura S; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K
Eur J Haematol; 2005 Sep; 75(3):212-20. PubMed ID: 16104877
[TBL] [Abstract][Full Text] [Related]
19. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
